DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 119 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2016. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $14,139,000 | +77.0% | 1,347,810 | +146.0% | 1.27% | +63.1% |
| Q2 2016 | $7,987,000 | -24.2% | 547,810 | 0.0% | 0.78% | -23.7% |
| Q1 2016 | $10,540,000 | -30.7% | 547,810 | -13.0% | 1.02% | +8.8% |
| Q4 2015 | $15,214,000 | -21.5% | 629,710 | -20.3% | 0.94% | -13.2% |
| Q3 2015 | $19,379,000 | +8.0% | 789,710 | +3.1% | 1.08% | +11.8% |
| Q2 2015 | $17,944,000 | +4.4% | 766,010 | 0.0% | 0.96% | -28.0% |
| Q1 2015 | $17,182,000 | -33.5% | 766,010 | -50.0% | 1.34% | +19.2% |
| Q4 2014 | $25,830,000 | – | 1,532,020 | – | 1.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
| Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
| Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
| Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
| Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
| Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
| AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
| HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
| Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
| Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |